Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.39 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.35 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.33 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.33 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15956052 | 0.92 | LPAR1 (0.39) | CTDSP1LPAR1LPAR3ENPP2 | |
| SCHEMBL15956025 | 0.89 | CTDSP1 (0.40) | CTDSP1 | |
| SCHEMBL17854895 | 0.88 | CTDSP1 (0.38) | CTDSP1 | |
| SCHEMBL17854784 | 0.87 | CTDSP1 (0.35) | CTDSP1LMNAPOLB | |
| SCHEMBL15955777 | 0.86 | CTDSP1 (0.38) | CTDSP1 | |
| SCHEMBL15955988 | 0.85 | CTDSP1 (0.37) | CTDSP1NLRP3 | |
| SCHEMBL15955749 | 0.83 | CTDSP1 (0.36) | CTDSP1 | |
| SCHEMBL2297204 | 0.80 | CA2 (0.49) | NLRP3LPAR1LPAR3ENPP2LMNA | |
| SCHEMBL21136083 | 0.80 | CTDSP1 (0.43) | CTDSP1LPAR1LPAR3ENPP2LMNA | |
| SCHEMBL21525856 | 0.80 | CTDSP1 (0.34) | CTDSP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10239116-B2 | Solvent system and compositions therewith | RHODIA POLIAMIDA E ESPECIALIDADES LTDA (BR) | 2019-03-26 | — | — | US | disclosed |
| EP-2956513-B1 | SOLVENT SYSTEM AND COMPOSITIONS THEREWITH | RHODIA POLIAMIDA E ESPECIALIDADES LTDA (BR) | 2017-09-27 | — | — | EP | disclosed |
| EP-2956513-A1 | SOLVENT SYSTEM AND COMPOSITIONS THEREWITH | Rhodia Poliamida E Especialidades Ltda (BR) | 2015-12-23 | — | — | EP | disclosed |
| US-20150361281-A1 | SOLVENT SYSTEM AND COMPOSITIONS THEREWITH | RHODIA POLIAMIDA E ESPECIALIDADES LTDA (BR) | 2015-12-17 | — | — | US | disclosed |
| WO-2014125357-A1 | SOLVENT SYSTEM AND COMPOSITIONS THEREWITH | RHODIA POLIAMIDA E ESPECIALIDADES LTDA (BR) | 2014-08-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150361281-A1 | SOLVENT SYSTEM AND COMPOSITIONS THEREWITH | DECR1, SQLE, DECR2 | CTDSP1 696/4885NLRP3 1427/4885LPAR1 119/4885 |
| US-10239116-B2 | Solvent system and compositions therewith | DECR1, SQLE, DECR2 | CTDSP1 696/4885NLRP3 1427/4885LPAR1 119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.